Pfizer Terminates Phase 3 Trial Of Figitumumab In Non-small Cell Lung Cancer
Source: Quote.com
Friday 12th March, 2010
PFE ) announced the termination of a Phase 3 clinical trial examining the effects of investigational compound figitumumab with erlotinib as a second/third-line treatment in patients with non-small c... ...
Read the full story at
Quote.com
Email this story to a friend
Have your say on this story